S1 Ep81: Pipeline Perspectives: Fruquintinib in Metastatic Colorectal Cancer
In this episode of  the ONCOLOGY On the Go Podcast, Arvind N. Dasari, MD, and Cathy Eng, MD, speak to data supporting fruquintinib (Elunate), a VEGFR-1, -2, and -3 inhibitor as a potential treatment for patients with metastatic colorectal cancer (CRC). Dasari is an associate professor in the Department of Gastrointestinal Medical Oncology in the Division of Cancer Medicine at The University of...
21m Oct 02, 2023
21m
S1 Ep80: Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances
CancerNetwork® spoke with experts across multiple disciplines about the far-reaching impacts of the ongoing shortages of chemotherapy drugs including carboplatin and cisplatin, and how practices may be able to mitigate these challenges in the short and long term. Michael Ganio, PharmD, MS, BCPS, FASHP, described the causes of carboplatin and cisplatin being in short supply across the United St...
22m Sep 11, 2023
22m
S1 Ep79: Frontline Forum: Testing and Targeted Therapy in EGFR Exon20+ NSCLC
As part of a CancerNetwork® Frontline Forum program, Alexander I. Spira, MD, PhD, FACP; Millie Das, MD; Joshua K. Sabari, MD; and Misako Nagasaka, MD, PhD, reviewed updates in the management of EGFR exon 20 non–small cell lung cancer (NSCLC), and how these findings may apply to clinical practice. Spira, codirector of the Virginia Cancer Specialists Research Institute and director of the Thorac...
54m Sep 04, 2023
54m
S1 Ep78: Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma
As part of a CancerNetwork® Frontline Forum program, Joselle Cook, MBBS; Matthew James Pianko, MD; Luciano Costa, MD, PhD; and Timothy Schmidt, MD, reviewed key data updates and real-world practice findings in newly diagnosed multiple myeloma (NDMM), and how they may impact patient subgroups including those with transplant-ineligible NDMM. Cook, a hematologist specializing in the management of...
49m Aug 14, 2023
49m
S1 Ep77: Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023
In a Twitter Spaces edition of the Oncology-On-The-Go podcast, Rafael Fonseca, MD and Krina Patel, MD, MSc spoke with CancerNetwork® about how key findings from multiple myeloma trials presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (https://www.cancernetwork.com/conference/asco-hematology) may impact the treatment paradigm. Fonseca, director of Innovation and...
33m Aug 07, 2023
33m
S1 Ep76: Sarcoma Awareness Month 2023 with Brian Van Tine, MD, PhD
In a conversation with CancerNetwork® during July’s Sarcoma Awareness Month 2023 (https://www.cancernetwork.com/awareness-month/july-2023-sarcoma-awareness-month) , Brian Van Tine, MD, PhD, spoke about developments in the sarcoma research space and discussed where future research needs to be focused in order to push the needle forward in the treatment of this patient across numerous sarcoma sub...
13m Jul 31, 2023
13m
S1 Ep75: Oncology On-The-Go Podcast: Secondary Cancer Susceptibility in Cancer Survivors
In a conversation with CancerNetwork® during June’s National Cancer Survivor Month, Lindsay Morton, PhD, spoke about her research on the long-term risks of developing second cancers among cancer survivors. Morton, director of the Radiation Epidemiology Branch and head of the Cancer Survivorship Research Unit at the National Cancer Institute and member of the Lymphoma Research Foundation’s Scie...
20m Jun 27, 2023
20m
S1 Ep74: Oncology On-The-Go Podcast: ASCO 2023 Recap
Ritu Salani, MD, and Tanios S. Bekaii-Saab, MD, FACP, spoke with CancerNetwork® about key findings presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (https://www.cancernetwork.com/conference/asco) , and how they may affect clinical practice for gynecologic cancer and gastrointestinal cancer. Salani, the Gynecologic Oncology Fellowship Director at University of C...
40m Jun 19, 2023
40m
S1 Ep73: Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer
Margaret Rosenzweig, PhD, CRNP-C, AOCNP, FAAN, spoke with CancerNetwork® about findings from the CONNECT study (NCT02712229) (https://www.cancernetwork.com/view/nursing-led-palliative-cancer-care-may-improve-advanced-care-planning) , a study she authored that aimed to assess the benefit of palliative care intervention in patients with advanced cancer. Rosenzweig, the distinguished service prof...
10m May 15, 2023
10m
S1 Ep72: Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
Rakhshanda Rahman, MD, FRCS, FACS, interviewed with CancerNetwork® regarding advancements in the systemic and surgical de-escalation of breast cancer treatment, which include wire-free markers that help define the extent of a tumor during surgery. Rahman, a professor of Breast Surgical Oncology at Texas Tech University Health Sciences Center and the medical director of UMC Cancer Center, discu...
18m May 08, 2023
18m
S1 Ep71: Oncology-On-The-Go Podcast: Signaling Pathways in Glioblastoma Relapse
Javier Orozco-Mera, MD, FACS, MSc, a neurosurgeon in the Department of Neurosurgery at Hospital Universitario del Valle “Evaristo García,” University of Valle, spoke with CancerNetwork® about his study titled, Signaling Pathways in the Relapse of Glioblastoma, (https://www.cancernetwork.com/view/signaling-pathways-in-the-relapse-of-glioblastoma) which was published in the journal ONCOLOGY®. In...
22m May 01, 2023
22m
S1 Ep70: Oncology On-The-Go Podcast: SGO 2023 Recap
In a Twitter Spaces edition of the Oncology On-The-Go podcast, Ritu Salani, MD, and Dana Chase, MD, spoke with CancerNetwork® about findings presented at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, (https://www.cancernetwork.com/conference/sgo) and how they may impact clinical practice. Salani, the Gynecologic Oncology Fellowship Director at University of C...
40m Apr 24, 2023
40m
S1 Ep69: Oncology On-The-Go Podcast: COVID-19 Vaccination and Cellular Therapy in Cancer
Fareed Khawaja, MBBS, assistant professor in the Department of Infectious Diseases, Infection Control, and Employee Health at The University of Texas MD Anderson Cancer Center, and Marilyne Daher, MD, medical resident in the Department of Internal Medicine at Baylor College of Medicine, spoke with CancerNetwork® about their study titled COVID-19 Vaccination in Patients with Cancer and Recipient...
19m Apr 17, 2023
19m
S1 Ep68: Oncology On-The-Go Podcast: Multiple Myeloma Outcome Disparities, Trial Access
In a conversation with CancerNetwork® during March’s Myeloma Awareness Month, Krina Patel, MD, MSc, spoke about disparities in outcomes and clinical trial access for patients with multiple myeloma. Patel, associate professor in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discussed previous research focusing on how ...
22m Apr 12, 2023
22m
S1 Ep67: Oncology On-The-Go Podcast: Integrative and Palliative Kidney Cancer Care
As part of Kidney Cancer Awareness Month 2023, (https://www.cancernetwork.com/awareness-month/march-2023-kidney-cancer-awareness-month) Santosh Rao, MD, spoke with CancerNetwork® about recent developments and initiatives that have helped to advance integrative and palliative care for patients with kidney cancer, including developments that read out of the Annual Society for Integrative Oncology...
23m Mar 28, 2023
23m
S1 Ep66: Oncology On-The-Go Podcast: Time to Treatment for Breast Cancer in Rural Populations
Minh-Tri Nguyen, MD, a hematology and oncology fellow at Cleveland Clinic Taussig Cancer Institute, spoke with CancerNetwork® about his study titled Shorter Time to Treatment Is Associated With Improved Survival in Rural Patients With Breast Cancer Despite Other Adverse Socioeconomic Factors (https://www.cancernetwork.com/view/journal-shorter-time-to-treatment-is-associated-with-improved-surviv...
14m Feb 27, 2023
14m
S1 Ep65: Oncology On-the-Go Podcast: Sacituzumab Govitecan for HR+/HER2– Advanced Breast Cancer
In a Twitter Spaces edition of the Oncology On-the-Go podcast, Kevin Kalinsky, MD, MS, and Jane Meisel, MD, of Emory Winship Cancer Institute, spoke with CancerNetwork® about how the FDA approval of sacituzumab govitecan-hziy (https://www.cancernetwork.com/view/fda-approves-sacituzumab-govitecan-hziy-in-pre-treated-hr-her2-advanced-breast-cancer) (Trodlevy) for advanced or metastatic hormone re...
29m Feb 20, 2023
29m
S1 Ep64: Oncology Peer Review On-The-Go Podcast: Cervical Cancer Screenings/Survival in Those 65+ Years
Julianne Cooley, MS, a computational and data science research specialist at the California Cancer Reporting and Epidemiologic Surveillance in the University of California Davis Comprehensive Cancer Center, spoke with CancerNetwork® about her research on cervical cancer screening and survival rate patterns among patients 65 years and older. In her study, Cooley explored how survival rates amon...
11m Feb 02, 2023
11m
S1 Ep63: Oncology Peer Review On-The-Go: Integrative Oncology in Young Population with Breast Cancer
Yancey Warren, Jr, MD, MAT, a breast surgery oncology fellow at Brown University, and Lejla Hadzikadic-Gusic, MD, MSc, associate professor of surgery, Division of Surgical Oncology at Atrium Health Levine Cancer Institute, spoke with CancerNetwork® about their study titled Integrative Oncology in Young Women with Breast Cancer, (https://www.cancernetwork.com/view/journal-integrative-oncology-in...
17m Jan 16, 2023
17m
S1 Ep62: Oncology Peer Review On-The-Go: Experts Share Multidisciplinary Takeaways From 2022 SABCS
During the 2022 San Antonio Breast Cancer Symposium (SABCS) (https://www.cancernetwork.com/conference/san-antonio-breast-cancer-symposium) , CancerNetwork® spoke with several multidisciplinary oncology experts from the Mayo Clinic in Rochester, Minnesota about their respective key takeaways from the presentations on developments in the breast cancer space, including surgery, radiotherapy, and b...
14m Dec 26, 2022
14m
S1 Ep61: Oncology Peer Review On-The-Go: Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer
Ibrahim Halil Sahin, MD, a medical oncologist specializing in gastrointestinal oncology and an assistant professor at the University of Pittsburgh Medical Center, Hillman Cancer Center, spoke with CancerNetwork® about his manuscript titled Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US (https://www.cancernetwork.com/view/journal-minim...
16m Nov 14, 2022
16m
S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma
As part of the Between the Lines (https://www.cancernetwork.com/between-the-lines) ™ video series, Bruce Cheson, MD, FACP, FAAAS, FASCO, a board certified hematologist at the Center for Cancer and Blood Disorders in Bethesda, Maryland, spoke with Steven Park, MD, an oncologist and vice chair of Research at the Atrium Health Levine Cancer Institute and a clinical professor of Medicine at Wake Fo...
21m Nov 03, 2022
21m
S1 Ep60: Oncology Peer Review On-The-Go: Cancer Pain and Opioid Use Disorder
Daniel C. McFarland, DO, and Dr. Kirk Harris, MD, both of the University of Rochester, spoke with CancerNetwork® about their manuscript titled, “Cancer Pain and Opioid Use Disorder (https://www.cancernetwork.com/view/journal-cancer-pain-and-opioid-use-disorder) ,” which was recently published in the journal ONCOLOGY®. In the review, the authors explore current approaches for screening of opioi...
24m Oct 31, 2022
24m
S1 Ep59: Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology
Coauthors Dori Beeler, PhD, of the Levine Cancer Institute; Shelley Wang, MD, MPH, of The University of Texas MD Anderson Cancer Center; and Viraj A. Master, MD, PhD, of the Winship Cancer Institute of Emory University, spoke with CancerNetwork® about their review published in the journal ONCOLOGY® titled Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and...
20m Sep 19, 2022
20m
S1 Ep58: Oncology Peer Review On-The-Go: Current Treatments in Peripheral T-cell Lymphoma
Robert Stuver, MD, and Zachary D. Epstein-Peterson, MD, spoke with CancerNetwork® about a review article on the treatment of peripheral T-cell lymphoma published in the journal ONCOLOGY®.
19m Aug 22, 2022
19m
S1 Ep56: Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma
Juan Pablo Alderuccio, MD, assistant professor of medicine in the Division of Hematology, Department of Medicine at the Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine in Florida, spoke with CancerNetwork® about his review published in the journal ONCOLOGY® titled, Current Treatments in Marginal Zone Lymphoma (https://www.cancernetwork.com/view/journal...
19m Aug 09, 2022
19m
S1 Ep55: Oncology Peer Review On-The-Go: The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study
Kira MacDougall, MD, a first year fellow at the University of Oklahoma, and Muhammad Rafay Khan Niazi, MD, a third year resident of Internal Medicine at Staten Island University Hospital, spoke with CancerNetwork® about research published in the journal ONCOLOGY® titled, The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With ...
14m Jul 25, 2022
14m
S1 Ep54: Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular Lymphoma
Kirk E. Cahill, MD, and Sonali M. Smith, MD, both of the Department of Medicine, Section of Hematology/Oncology at the University of Chicago Medicine Comprehensive Cancer Center in Chicago, Illinois, spoke about their manuscript titled, ‘Follicular Lymphoma: a Focus on Current and Emerging Therapies (https://www.cancernetwork.com/view/journal-follicular-lymphoma-a-focus-on-current-and-emerging-...
19m Jul 11, 2022
19m
S1 Ep57: Oncology Peer Review On-The-Go: Paolo Tarantino, MD, and Sara Tolaney, MD, Review Data in the Treatment of Breast Cancer at 2022 ASCO
In the inaugural Twitter Spaces edition of the Oncology Peer Review On-The-Go podcast hosted by CancerNetwork®, Paolo Tarantino, MD, a clinical research fellow at Dana-Farber Cancer Institute, and Sara M. Tolaney, MD, MPH, chief of the Division of Breast Oncology and associate director of the Susan F. Smith Center for Women’s Cancer at Dana-Farber as well as an associate professor of medicine a...
44m Jun 30, 2022
44m
S1 Ep52: Oncology Peer Review On-The-Go: Financial Conflicts of Interest Among Junior Faculty in Hematology and Oncology
Suneel D. Kamath, MD, of the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, spoke with the editorial team of the journal ONCOLOGY® about his published manuscript titled, ‘Association of Financial Conflicts of Interest With Academic Productivity Among Junior Faculty in Hematology and Oncology (https://www.cancernetwork.com/view/journal-association-of-financial-conflicts-of-interes...
13m Jun 27, 2022
13m
S1 Ep51: Oncology Peer Review On-The-Go: Academic Promotion and Oncology Drug Development
Nora Janjan, MD, MPSA, MBA, who sits on the editorial advisory board for the journal ONCOLOGY®, spoke about her perspective titled, ‘Academic Promotion and Oncology Drug Development: Role, Responsibilities, and Integrity (https://www.cancernetwork.com/view/journal-academic-promotion-and-oncology-drug-development-role-responsibilities-and-integrity) .’    In the article, Janjan explores the ro...
16m Jun 20, 2022
16m
S1 Ep25: Oncology Peer Review On-The-Go: Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs
This week, CancerNetwork® spoke with Judd W. Moul, MD, editorial board member for the journal ONCOLOGY® and James H. Semans, MD, Distinguished Professor of Urologic Surgery at Duke University School of Medicine, leads a discussion with medical student Kostantinos E. Morris, from Duke University School of Medicine, on research recently published in the journal ONCOLOGY®titled, ‘Successful Diagno...
21m May 30, 2022
21m
S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma
Paul G. Richardson, MD, and Christina Gasparetto, MD, offer insights into the use of proteasome inhibitors in relapsed or refractory multiple myeloma.   As part of its Between the Lines™ video series, CancerNetwork® spoke with Paul G. Richardson, MD, clinical program leader and director of Clinical Research for the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute in Bosto...
22m May 20, 2022
22m
S1 Ep50: Tanios Bekaii-Saab, MD, and Experts Examine Therapy Resistance in CRC
This week, CancerNetwork looks at the final part of its 3-part series focused on colorectal cancer. Tanios Bekaii-Saab, MD, a gastrointestinal cancers (GI) medical oncologist at the Mayo Clinic Cancer Center, concludes his conversation with Kristen Ciombor, MD, MSCI, a GI medical oncologist and associate professor of medicine at Vanderbilt-Ingram Cancer Center, and John Strickler, MD, a GI medi...
16m May 16, 2022
16m
S1 Ep49: Tanios Bekaii-Saab, MD, and Colleagues Discuss GOZILA Platform for CRC
This week, CancerNetwork turns to the second part of its 3-part series focused on colorectal cancer. Tanios Bekaii-Saab, MD, a gastrointestinal cancers (GI) medical oncologist at the Mayo Clinic Cancer Center, continues the conversation with Kristen Ciombor, MD, MSCI, a GI medical oncologist and associate professor of medicine at Vanderbilt-Ingram Cancer Center, and John Strickler, MD, a GI med...
12m May 16, 2022
12m
S1 Ep48: Tanios Bekaii-Saab, MD, Talks COLOMATE Platform for CRC With GI Experts
This week, CancerNetwork kicks off the first of a 3-part podcast series focused on colorectal cancer. Tanios Bekaii-Saab, MD, a gastrointestinal cancers (GI) medical oncologist at the Mayo Clinic Cancer Center, leads a conversation with Kristen Ciombor, MD, MSCI, a GI medical oncologist and associate professor of medicine at Vanderbilt-Ingram Cancer Center, and John Strickler, MD, a GI medical ...
17m May 09, 2022
17m
S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer
As part of its OncView™ program, CancerNetwork hosted a discussion Lori Wirth, MD, associate professor of medicine at Harvard Medical School and medical director of the Center for Head and Neck Cancers at Massachusetts General Hospital in Boston, who shared her perspective on updates in the treatment of second-line radioiodine-refractory differentiated thyroid cancer, or DTC.   In the video s...
35m May 06, 2022
35m
S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC
As part of its OncView™ video series, CancerNetwork® spoke with David H. Aggen, MD, PhD, of the Memorial Sloan Kettering Cancer Center, Robert S. Alter, MD, of the John Theurer Cancer Center, Arnab Basu, MD, MPH, of the O’Neal Comprehensive Cancer Center, Mehmet Asim Bilen, MD, of Winship Cancer Institute, and Chung-Han Lee, MD, MPH, of Memorial Sloan Kettering Cancer Center, who shared their t...
30m Apr 29, 2022
30m
S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC
OncView™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC   As part of its OncView™ video series, CancerNetwork® spoke with Gregory Riely, MD, PhD, vice chair of Clinical Research in the Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, and Tarek Mekhail, MD, a hematologic oncologist from Advent Health in Florida, ...
28m Apr 27, 2022
28m
S1 Ep47: Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma
This week, CancerNetwork® spoke with Christine Chung, DO, of the Swedish Medical Center, Englewood, Colorado, about “Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma (https://www.cancernetwork.com/view/journal-characterization-of-blood--based-molecular-profiling-in-pancreatic-adenocarcinoma) ,” a retrospective review published in the journal ONCOLOGY.   Chung d...
8m Apr 25, 2022
8m
S1 Ep46: PARP Inhibitors as Maintenance Therapy for Metastatic CRPC
This week, CancerNetwork® spoke with Muhammad Niazi, MD, resident in internal medicine at Staten Island University Hospital, and Alexander Bershadskiy, MD, attending physician at Staten Island University Hospital, about a meta-analysis published in ONCOLOGY titled, “Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomi...
13m Apr 11, 2022
13m
S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC
As part of its OncView™ video series, CancerNetwork® spoke with Zofia Piotrowska, MD, an assistant professor of medicine at Harvard Medical School and a lung cancer medical oncologist at Massachusetts General Hospital, about recent data and review updates in the treatment landscape for patients with non-small-cell lung cancer and exon 20 insertions.   In the video series, Piotrowska discussed...
21m Apr 08, 2022
21m
S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer
As part of its Between the Lines™ video series, CancerNetwork® spoke with Liliana Bustamante, MD, hematologist and medical oncologist at Florida Cancer Specialists in Fort Myers, Florida and Richard Kim, MD, service chief of Medical Gastrointestinal Oncology and senior member in the Gastrointestinal Oncology Department at the Moffitt Cancer Center in Tampa, Florida, about the prognostic potenti...
25m Apr 05, 2022
25m
S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
As part of its OncView™ video series, CancerNetwork® spoke with John Kirkwood, MD, PhD, director of the melanoma center at the University of Pittsburgh Medical Center Hillman Cancer Center, about using immunotherapy for treating melanoma and how to monitor responses in patients properly.   In the video series, Kirkwood discussed the following:   ·      Treatment Options for Melanoma (https:...
44m Apr 02, 2022
44m
S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer
As part of its OncView™ video series, CancerNetwork® spoke with Roy Herbst, MD, PhD, chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, about currently available treatment options and strategies in immunotherapy for treating non–small cell lung cancer (NSCLC).   In the video series, Herbst discussed the following: ·      Treatment Options in...
18m Mar 30, 2022
18m
S1 Ep45: Real-World Assessment of Care and Efficiency With Subcutaneous Rituximab
This week, CancerNetwork spoke with Matthew Matasar, MD, a lymphoma specialist and chief of the Medical Oncology Service at Memorial Sloan Kettering Cancer Center Bergen, about research from the December issue of ONCOLOGY titled, “Real-World Assessment of Patient Care and Practice Efficiency With the Introduction of Subcutaneous Rituximab (https://www.cancernetwork.com/view/real-world-assessmen...
10m Mar 28, 2022
10m
S1 Ep44: Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer
CancerNetwork spoke with Jun Gong, MD, a practicing medical oncologist who specializes in the treatment of genitourinary cancers at Cedars-Sinai Medical Center, regarding a perspective piece titled, “Cisplatin Neoadjuvant Chemotherapy in an Aging Population With Muscle-Invasive Bladder Cancer (https://www.cancernetwork.com/view/journal-cisplatin-neoadjuvant-chemotherapy-in-an-aging-population-w...
13m Mar 14, 2022
13m
S1 Ep43: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial
CancerNetwork® recently spoke with Ofer Sharon, MD, CEO of OncoHost, about interim results from the prospective PROPHETIC trial to predict how patients with non–small cell lung cancer respond to immunotherapy.   Sharon first described OncoHost and the mission of this clinical stage precision oncology company. Then, he touched on the key details of this research, with a focus on the PROphet di...
15m Feb 28, 2022
15m
S1 Ep42: Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma
CancerNetwork® spoke with Emily Smith, MD, of the Ellis Fishchel Cancer Center, University of Missouri, about a patient case published in the December issue of the journal ONCOLOGY titled, “Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma (https://www.cancernetwork.com/view/journal-metastatic-basal-cell-carcinoma-arising-from-a-primary-cutaneous-carcinosarcoma) .”...
13m Feb 14, 2022
13m
S1 Ep41: Matthew Allaway, DO, on Transperineal Biopsy Approach for Prostate Cancer
CancerNetwork spoke with Matthew Allaway, DO, founder and CEO of Perineologic, about a new prostate cancer biopsy technique that uses the transperineal approach to detect cancer in harder to reach areas of the prostate. Allaway touched on the American Cancer Society’s annual report that shows the rate of advanced-stage prostate cancer cases are increasing in recent years. He also detailed a co...
18m Jan 31, 2022
18m